{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:02:54Z","timestamp":1792803774182,"version":"4.5.0"},"reference-count":35,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Damon Runyon Clinical Investigator Award provided by the Damon Runyon Cancer Research Foundation","award":["105\u201319"],"award-info":[{"award-number":["105\u201319"]}],"id":[{"id":"https:\/\/ror.org\/01gd7b947","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Damon Runyon Clinical Investigator Award provided by the Damon Runyon Cancer Research Foundation","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"https:\/\/ror.org\/01gd7b947","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Alex\u2019s Lemonade Stand Foundation","award":["105\u201319"],"award-info":[{"award-number":["105\u201319"]}],"id":[{"id":"https:\/\/ror.org\/038ja4880","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Alex\u2019s Lemonade Stand Foundation","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"https:\/\/ror.org\/038ja4880","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Lorenzo \u201cTurtle\u201d","award":["105\u201319"],"award-info":[{"award-number":["105\u201319"]}]},{"name":"Lorenzo \u201cTurtle\u201d","award":["-"],"award-info":[{"award-number":["-"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Patients with Beckwith\u2013Wiedemann syndrome (BWS), an epigenetic imprinting disorder involving alterations in genes at the 11p15 chromosomal location, are predisposed to develop hepatoblastomas (HBs), which are rare embryonal liver tumors. Tumors can develop after a BWS diagnosis or, conversely, can be the presenting feature leading to a subsequent diagnosis. While HBs are the cardinal tumors of BWS, not all patients with the BWS spectrum will develop HBs. This observation has led to many hypotheses, including genotype-associated risk, tissue mosaicism, and tumor-specific second hits. To explore these hypotheses, we present the largest cohort of patients with BWS and HBs to date. Our cohort comprised 16 cases, and we broadened our sample size by searching the literature for all cases of BWS with HBs. From these isolated case studies, we amassed another 34 cases, bringing the total number to 50 cases of BWS-HB. We observed that paternal uniparental isodisomy (upd(11)pat) was the most common genotype, representing 38% of cases. The next most common genotype was IC2 LOM, representing 14% of cases. Five patients had clinical BWS without a molecular diagnosis. To investigate the potential mechanism of HBs in BWS, we analyzed normal liver and HB samples from eight cases and isolated tumor samples from another two cases. These samples underwent methylation testing, and 90% of our tumor samples underwent targeted cancer next-generation sequencing (NGS) panels. These matched samples provided novel insights into the oncogenesis of HBs in BWS. We found that 100% of the HBs that underwent NGS panel testing had variants in the CTNNB1 gene. We further identified three distinct groups of BWS-HB patients based on epigenotype. We also demonstrated epigenotype mosaicism, where 11p15 alterations can differ between the blood, HB, and normal liver. In light of this epigenotype mosaicism, tumor risk assessment based on blood profiling may not be accurate. Therefore, universal screening is recommended for all patients with BWS.<\/jats:p>","DOI":"10.3390\/cancers15092548","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:55:09Z","timestamp":1683093309000},"page":"2548","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Occurrence of Hepatoblastomas in Patients with Beckwith\u2013Wiedemann Spectrum (BWSp)"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8634-0388","authenticated-orcid":false,"given":"Steven D.","family":"Klein","sequence":"first","affiliation":[{"name":"Division of Human Genetics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA 19104, USA"},{"name":"Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"DeMarchis","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Linn","sequence":"additional","affiliation":[{"name":"Department of Pathology and Lab Medicine, Perelman School of Medicine, Children\u2019s Hospital of Philadelphia, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne P.","family":"MacFarland","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA 19104, USA"},{"name":"Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA 19104, USA"},{"name":"Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-9713","authenticated-orcid":false,"given":"Jennifer M.","family":"Kalish","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA 19104, USA"},{"name":"Department of Pediatrics, Perelman School of Medicine, Philadelphia, PA 19104, USA"},{"name":"Center for Childhood Cancer Research, Children\u2019s Hospital of Philadelphia, Philadelphia, PA 19104, USA"},{"name":"Department of Genetics, Perelman School of Medicine, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e29763","DOI":"10.1002\/pbc.29763","article-title":"Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States","volume":"10","author":"Kahla","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"690641","DOI":"10.3389\/fonc.2021.690641","article-title":"The Genetic Changes of Hepatoblastoma","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/pbc.24213","article-title":"Genetics and epigenetics of hepatoblastoma","volume":"59","author":"Tomlinson","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1001\/jamaoncol.2021.4536","article-title":"Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes","volume":"7","author":"Goudie","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpedsurg.2021.08.008","article-title":"Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee","volume":"57","author":"Grant","year":"2022","journal-title":"J. Pediatr. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00431-021-04347-x","article-title":"The need for tumor surveillance of children and adolescents with cancer predisposition syndromes: A retrospective cohort study in a tertiary-care children\u2019s hospital","volume":"181","author":"Huber","year":"2022","journal-title":"Eur. J. Pediatr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1158\/1078-0432.CCR-17-0710","article-title":"Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma","volume":"23","author":"Kalish","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1158\/1078-0432.CCR-17-0790","article-title":"Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood","volume":"23","author":"Achatz","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrendo.2017.166","article-title":"Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: An international consensus statement","volume":"14","author":"Brioude","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/ajmg.c.31740","article-title":"Characterization of the Beckwith-Wiedemann spectrum: Diagnosis and management","volume":"181","author":"Duffy","year":"2019","journal-title":"Am. J. Med Genet. Part C: Semin. Med Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1002\/cncr.32907","article-title":"11p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood","volume":"126","author":"Fiala","year":"2020","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Duffy, K.A., Getz, K.D., Hathaway, E.R., Byrne, M.E., MacFarland, S.P., and Kalish, J.M. (2021). Characteristics Associated with Tumor Development in Individuals Diagnosed with Beckwith\u2013Wiedemann Spectrum: Novel Tumor-(epi)Genotype-Phenotype Associations in the BWSp Population. Genes, 12.","DOI":"10.3390\/genes12111839"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(80)80322-2","article-title":"Complete and incomplete forms of Beckwith-Wiedemann syndrome: Their oncogenic potential","volume":"96","author":"Fowler","year":"1980","journal-title":"J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0022-3476(98)70008-3","article-title":"Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry","volume":"132","author":"DeBaun","year":"1998","journal-title":"J. Pediatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jpeds.2004.08.007","article-title":"Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS)","volume":"145","author":"Bliek","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/ajmg.a.37801","article-title":"Phenotype, cancer risk, and surveillance in Beckwith-Wiedemann syndrome depending on molecular genetic subgroups","volume":"170","author":"Maas","year":"2016","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1093\/hmg\/10.26.2989","article-title":"Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1","volume":"10","author":"Weksberg","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2016.05.038","article-title":"Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol","volume":"176","author":"Mussa","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajmg.a.38068","article-title":"The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome","volume":"173","author":"Duffy","year":"2017","journal-title":"Am. J. Med Genet. Part A"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cge.12759","article-title":"Fetal growth patterns in Beckwith-Wiedemann syndrome","volume":"90","author":"Mussa","year":"2016","journal-title":"Clin. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/jmedgenet-2019-106498","article-title":"Improved molecular detection of mosaicism in Beckwith-Wiedemann Syndrome","volume":"58","author":"Baker","year":"2021","journal-title":"J. Med Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/hmg\/ddq003","article-title":"Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis","volume":"19","author":"Conlin","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejmg.2012.12.001","article-title":"Hepatoblastoma in a child with a paternally-inherited ABCC8 mutation and mosaic paternal uniparental disomy 11p causing focal congenital hyperinsulinism","volume":"56","author":"Calton","year":"2013","journal-title":"Eur. J. Med Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00280564","article-title":"Loss of alleles on the short arm of chromosome 11 in a hepatoblastoma from a child with Beckwith-Wiedemann syndrome","volume":"79","author":"Little","year":"1988","journal-title":"Hum. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e26241","DOI":"10.1002\/pbc.26241","article-title":"Novel deletion in 11p15.5 imprinting center region 1 in a patient with Beckwith-Wiedemann syndrome provides insight into distal enhancer regulation and tumorigenesis","volume":"64","author":"Bachmann","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-4608(86)90409-7","article-title":"Constitutional interstitial deletion of 11p11 and pericentric inversion of chromosome 9 in a patient with Wiedemann-Beckwith syndrome and hepatoblastoma","volume":"23","author":"Haas","year":"1986","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.21037\/jgo.2018.01.08","article-title":"Histological and immunohistochemical study of hepatoblastoma: Correlation with tumour behaviour and survival","volume":"9","author":"Kiruthiga","year":"2018","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.sempedsurg.2016.09.002","article-title":"Malignant tumors of the liver in children","volume":"25","author":"Aronson","year":"2016","journal-title":"Semin. Pediatr. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: Proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"Alaggio","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/hep4.1972","article-title":"Molecular networks of hepatoblastoma predisposition and oncogenesis in Beckwith-Wiedemann syndrome","volume":"6","author":"Naveh","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_33","first-page":"8","article-title":"Mutation Hotspots in the beta-Catenin Gene: Lessons from the Human Cancer Genome Databases","volume":"42","author":"Kim","year":"2019","journal-title":"Mol. Cells"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Larsen, L.J., and M\u00f8ller, L.B. (2020). Crosstalk of Hedgehog and mTORC1 Pathways. Cells, 9.","DOI":"10.3390\/cells9102316"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"a006115","DOI":"10.1101\/mcs.a006115","article-title":"Epigenetic mosaicism and cell burden in Beckwith\u2013Wiedemann syndrome due to loss of methylation at imprinting control region 2","volume":"7","author":"Duffy","year":"2021","journal-title":"Cold Spring Harb. Mol. Case Stud."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/9\/2548\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:26:20Z","timestamp":1760124380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/9\/2548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,29]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["cancers15092548"],"URL":"https:\/\/doi.org\/10.3390\/cancers15092548","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,29]]}}}